WO2017206016A1 - 外敷消炎消肿中药膏剂 - Google Patents

外敷消炎消肿中药膏剂 Download PDF

Info

Publication number
WO2017206016A1
WO2017206016A1 PCT/CN2016/083896 CN2016083896W WO2017206016A1 WO 2017206016 A1 WO2017206016 A1 WO 2017206016A1 CN 2016083896 W CN2016083896 W CN 2016083896W WO 2017206016 A1 WO2017206016 A1 WO 2017206016A1
Authority
WO
WIPO (PCT)
Prior art keywords
traditional chinese
parts
chinese medicine
swelling
inflammatory
Prior art date
Application number
PCT/CN2016/083896
Other languages
English (en)
French (fr)
Inventor
吴克
Original Assignee
江苏奇力康皮肤药业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江苏奇力康皮肤药业有限公司 filed Critical 江苏奇力康皮肤药业有限公司
Priority to CN201680000512.5A priority Critical patent/CN108495645B/zh
Priority to PCT/CN2016/083896 priority patent/WO2017206016A1/zh
Publication of WO2017206016A1 publication Critical patent/WO2017206016A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Definitions

  • the invention relates to a traditional Chinese medicine ointment. More specifically, the present invention relates to a traditional Chinese medicine ointment having an external application of anti-inflammatory and swelling.
  • the external Chinese medicine ointment is an external semi-solid dosage form which is easily mixed on the skin surface and is prepared by mixing the medicinal material extract with a suitable medium, and has the advantages of good adhesion, spreadability, convenient use and the like.
  • TCM external application ointment uses the synergistic effect of drugs to form a large compound of multi-flavor drugs, in order to exert the good effect of the drug, the traditional Chinese medicine ointment is applied to the surface of the plaster to stimulate the nerve endings, through the reflection, dilation of blood vessels, and promotion of local blood Circulation, improve the nutrition of the surrounding tissues, so as to achieve the purpose of swelling, anti-inflammatory and analgesic.
  • the drug penetrates the subcutaneous tissue through the skin in the affected area, and the relative advantage of the drug concentration is locally generated, thereby exerting a strong pharmacological effect.
  • the traditional external application of anti-inflammatory and swelling Chinese medicine ointment has the following disadvantages: (1) Only the efficacy of traditional Chinese medicine is considered when formulating the ointment, but its toxicity and irritation are neglected, which may aggravate the discomfort of the patient; (2) the traditional external application of ointment The transdermal absorption effect is poor, and the ideal therapeutic effect is not achieved; (3) The traditional Chinese medicine ointment mostly uses sesame oil to extract the traditional Chinese medicine component, and it is easy to extract the active ingredient or the active ingredient in the medicinal material due to the excessive temperature.
  • the inventors of the present invention have found that by properly combining nine kinds of Chinese herbal medicines, they are non-irritating to the skin, and are processed according to the characteristics of each Chinese herbal medicine and the extraction of active ingredients.
  • a transdermal enhancer composed of a suitable ratio of menthol, borneol, PEG, and octanol is also added to the traditional Chinese medicine ointment of the present invention, which significantly increases the therapeutic effect of the traditional Chinese medicine external application ointment. Based on this finding, the present invention has been completed.
  • Still another object of the present invention is to provide an external application of an anti-inflammatory and swelling traditional Chinese medicine ointment, which can quickly reduce inflammation and reduce swelling, has remarkable curative effect, is convenient to use, and is non-irritating to the skin.
  • an externally applied anti-inflammatory and anti-inflammatory Chinese medicine ointment comprising, by weight, consisting of the following grouping ratios:
  • sea buckthorn core, cork, raw land, chamomile flower, forsythia, uncaria, pumpkin seed, Chuanxiong and VB 5 can produce strong and long-lasting heat-clearing, anti-inflammatory and swelling-reducing effects.
  • Seabuckthorn oil in seabuckthorn fruit nucleus can resist anti-inflammatory muscles and promote tissue regeneration.
  • Phellodendron has strong inhibitory effect on various pathogenic bacteria, and has astringent and anti-inflammatory effects.
  • the habitat can be used for stagnation of blood circulation and blood circulation.
  • Huayu Chrysanthemum has excellent anti-inflammatory and anti-inflammatory effects, relieves pain and swelling, promotes wound healing, and promotes cell regeneration and skin metabolism.
  • Forsythia treats heat-clearing and detoxifying, swelling and dispersing; Uncaria can be used for Shujinhuo It can reduce swelling and analgesia; pumpkin seeds have anti-inflammatory and analgesic effects; Chuanxiong can be used for activating blood circulation and phlegm and relieving pain; proper addition of VB 5 can be used to soothe the skin and promote the recovery of skin health.
  • the transdermal enhancer comprises 30-40% by weight of menthol, 30-40% by weight of borneol, 15-20% by weight of PEG and 10-15% by weight of octanol.
  • menthol can change the permeability of the stratum corneum, reduce the resistance of the drug to penetration through the skin, and improve the diffusion system of the drug in the stratum corneum of the skin.
  • the borneol can synergize with menthol to effectively increase the absorption of the drug by the skin; PEG and octanol can fuse and mix traditional Chinese medicine with menthol and borneol, which not only increases the solubility of the drug, but also significantly improves the long-term effect of the penetration-promoting effect.
  • the molecular weight of the PEG is 400-600. Under this molecular weight, the PEG has good compatibility with drugs and other excipients, and has an optimal promoting effect on the transdermal efficiency of the drug.
  • the sea buckthorn core, the yellow cedar, the raw land, the hook vine, the chuanxiong, respectively, are pulverized, mixed, and then extracted with 85% ethanol as a solvent at 80 ° C for 3 times to promote the dissolution of the active ingredient of the traditional Chinese medicine. .
  • the chamomile flower, forsythia, and pumpkin seeds are respectively pulverized, mixed, and then extracted with 70% ethanol as a solvent at 55 to 60 ° C for 2 times, chamomile flowers, forsythia and pumpkin.
  • the ethanol reflux extraction temperature of the child should not be too high, otherwise it will increase the dissolution of the ineffective components and reduce the efficacy.
  • the sea buckthorn core, the yellow cedar, the raw land, the genus Uncaria, and the Chuanxiong are respectively pulverized to 20 to 25 ⁇ m, thereby ensuring the leaching of the active ingredient of the traditional Chinese medicine and preventing the fine particle size of the traditional Chinese medicine from affecting the filtration.
  • the 85% ethanol is 5-8 times of the mixed volume of Hippophae rhamnoides, Cork, S. chinensis, Uncaria and Chuanxiong, and the time of each extraction is 1-2 h, suitable ratio of material to liquid and extraction time Ensure the mass transfer driving force and increase the extraction rate of effective substances.
  • the chamomile flower, forsythia, and pumpkin seed are respectively pulverized to 28 to 32 ⁇ m, so that the active ingredient of the traditional Chinese medicine can be sufficiently dissolved to ensure a balance between the dissolution rate of the active ingredient and the pulverization energy.
  • the 70% ethanol is 4-5 times of the chamomile flower, forsythia and pumpkin seeds, and the time of each extraction is 0.3-0.7 h to ensure the active ingredient of the traditional Chinese medicine.
  • transdermal enhancer consisting of a suitable ratio of menthol, borneol, PEG and octanol in the present invention effectively changes the permeability of the stratum corneum of the skin, reduces the resistance of the drug to penetration through the skin, and improves the drug in The diffusion system of the stratum corneum of the skin, and the prolongation effect is long-lasting;
  • the present invention replaces the traditional sesame oil extraction method, and adopts different alcohol reflux processes for extraction according to different properties of the Chinese herbal medicine, thereby ensuring sufficient extraction of the active ingredients and avoiding excessive impurities of the traditional Chinese medicine paste caused by excessive extraction temperature. Poor efficacy.
  • An external application of anti-inflammatory and swelling traditional Chinese medicine ointment which comprises, by weight, by the following group distribution ratio: 15 parts of sea buckthorn core; 10 parts of Phellodendron; 8 parts of habitat; 8 parts of chamomile flower; 5 parts of forsythia; Parts; 5 parts of pumpkin seeds; 3 parts of Chuanxiong; 3 parts of VB 5 ; 3 parts of transdermal enhancer.
  • the transdermal enhancer comprises 30% by weight of menthol, 40% by weight of borneol, 20% by weight of PEG400 and 10% by weight of octanol.
  • the seabuckthorn core, the yellow cedar, the raw land, the genus Uncaria, and the Chuanxiong are respectively pulverized to an average particle diameter of 20 ⁇ m, mixed, and then 8 times of ethanol of the Chinese medicine mixture is used as a solvent, and the mixture is refluxed at 80 ° C for 3 times.
  • the first time, each extraction is 1h; the chamomile flowers, forsythia, and pumpkin seeds are respectively pulverized to 28 ⁇ m, mixed, and then sequentially mixed with 4 times of chrysanthemum, forsythia and pumpkin seeds.
  • 70% ethanol was used as a solvent, and the extraction was carried out twice at 55 ° C, and the extraction time was 0.3 h.
  • An external application of anti-inflammatory and swelling traditional Chinese medicine ointment which comprises, by weight, by the following group distribution ratio: 20 parts of sea buckthorn core; 15 parts of Phellodendron; 12 parts of habitat; 12 parts of chamomile flower; 15 parts of forsythia; Parts; 10 parts of pumpkin seeds; 7 parts of Chuanxiong; 5 parts of VB 5 ; 5 parts of transdermal enhancer.
  • the transdermal enhancer comprises 40% by weight of menthol, 35% by weight of borneol, 15% by weight of PEG600 and 10% by weight of octanol.
  • the seabuckthorn core, the yellow cedar, the raw land, the genus Uncaria, and the Chuanxiong are respectively pulverized to an average particle diameter of 25 ⁇ m, mixed, and then 8 times of ethanol of 8 times of the Chinese medicine mixture is used as a solvent, and refluxed at 80 ° C for 3 times. Times, each extraction time is 2h.
  • the chamomile flower, forsythia, and pumpkin seeds are respectively pulverized to 32 ⁇ m, mixed, and then sequentially mixed with 70% ethanol of 5 times chamomile, forsythia and pumpkin seed volume, and refluxed at 60 ° C. 2 times, the time of each extraction is 0.7h.
  • the transdermal enhancer comprises 35 wt% menthol, 35 wt% borneol, 15 wt% PEG 500, and 15 wt% octanol.
  • the seabuckthorn core, the yellow cedar, the raw land, the genus Uncaria, and the Chuanxiong are respectively pulverized to an average particle diameter of 23 ⁇ m, mixed, and then 8 times of ethanol of the Chinese medicine mixture is used as a solvent, and the co-extraction is carried out at 80 ° C under reflux.
  • the extraction time is 2h, 1.5h and 1h respectively; the chamomile flower, forsythia,
  • the pumpkin seeds were pulverized to 30 ⁇ m, mixed, and then, with 4.5 times the volume of chamomile, forsythia and pumpkin seeds, 70% ethanol as solvent, and refluxed at 58 ° C for 2 times, the extraction time was 0.5 h and 0.7h.
  • the transdermal enhancer comprises 32% by weight of menthol, 38% by weight of borneol, 18% by weight of PEG400 and 12% by weight of octanol.
  • the seabuckthorn core, the yellow cedar, the raw land, the genus Uncaria, and the Chuanxiong are respectively pulverized to an average particle diameter of 22 ⁇ m, mixed, and then 8 times of ethanol of 8 times of the Chinese medicine mixture is used as a solvent, and refluxed at 80 ° C for 3 times.
  • the extraction time was 1.5h, 1.5h and 1h respectively; the chamomile flowers, forsythia and pumpkin seeds were pulverized to 29 ⁇ m, mixed, and then 4 times chamomile, forsythia and pumpkin mixture
  • the volume of 70% ethanol was used as a solvent, and the extraction was carried out twice at 58 ° C, and the extraction time was 0.7 h and 0.4 h, respectively.
  • An external application of anti-inflammatory and swelling traditional Chinese medicine ointment which comprises, by weight, by the following group distribution ratio: 17 parts of sea buckthorn kernel; 13 parts of cork; 9 parts of habitat; 11 parts of chamomile flower; 10 parts of forsythia; Servings; 8 parts of pumpkin seeds; 6 parts of Chuanxiong; 5 parts of VB 5 ; 4 parts of transdermal enhancer.
  • the transdermal enhancer comprises 36% by weight of menthol, 33% by weight of borneol, 17% by weight of PEG500 and 14% by weight of octanol.
  • the seabuckthorn core, the yellow cypress, the raw land, the genus Uncaria, and the Chuanxiong are respectively pulverized to an average particle diameter After 24 ⁇ m, the mixture was mixed with 85% ethanol of 7 times Chinese herbal medicine as solvent, and refluxed at 80 ° C for 3 times.
  • the extraction time was 1.5 h, 1 h and 2 h, respectively; the chamomile flower, forsythia, and pumpkin seeds were respectively After pulverizing to 31 ⁇ m, the mixture was mixed, and then 70 times of the volume of the mixture of chamomile flowers, forsythia and pumpkin seeds was used as a solvent, and the mixture was re-extracted twice at 59 ° C for 0.6 h and 0.5 h, respectively.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

一种外敷消炎消肿的中药膏剂，其按重量份计，由以下组分组成：沙棘果核15-20份、黄柏10-15份、地黄8-12份、春黄菊8-12份、连翘5-15份、钩藤5-15份、南瓜子5-10份、川芎3-7份、VB 53-5份、透皮促进剂3-5份。其中，所述透皮促进剂包括30-40wt%的薄荷醇、30-40wt%的冰片、15-20wt%的PEG和10-15wt%的辛醇。

Description

外敷消炎消肿中药膏剂 技术领域
本发明涉及一种中药膏剂。更具体地说，本发明涉及一种具有外敷消炎消肿的中药膏剂。
背景技术
外用中药膏剂是药材提取物与适宜介质混合制成的易于涂布于皮肤表面的外用半固体剂型，具有较好的附着性、涂展性、使用携带方便等优点。中医外敷药膏通过运用药物互相协调为用的效能，组成多味药物的大复方，以发挥药物的良好效果，将中药膏剂贴于体表的膏药刺激神经末梢，通过反射，扩张血管，促进局部血液循环，改善周围组织的营养，从而达到消肿、消炎和镇痛的目的。同时药物在患处通过皮肤渗透皮下组织，在局部产生药物浓度的相对优势，从而发挥较强的药理作用。
但传统的外敷消炎消肿中药膏剂有如下缺点：(1)配制膏剂时仅考虑到中药的功效，而忽视了其毒性和刺激性，反而会加重患者的不适现象；(2)传统外敷膏剂的透皮吸收效果差，达不到理想的治疗效果；(3)传统中药膏剂多以麻油进行中药成分的提取，易因温度过高破坏药材内的有效成分或有效成分提取不完整。
发明内容
作为各种广泛且细致的研究和实验的结果，本发明的发明人已经发现，通过将九种中草药进行合理配伍，对皮肤无刺激性，并根据每种中草药的特性进行处理和有效成分的提取，此外在本发明的中药膏剂中还添加由合适比例薄荷醇、冰片、PEG及辛醇组成的透皮促进剂，显著增加了本发明中药外敷膏剂的疗效。基于这种发现，完成了本发明。
本发明的一个目的是解决至少上述问题和/或缺陷，并提供至少后面将说 明的优点。
本发明还有一个目的是提供一种外敷消炎消肿中药膏剂，其能快速消炎消肿，疗效显著，使用方便，且对皮肤无刺激性。
为了实现根据本发明的这些目的和其它优点，提供了一种外敷消炎消肿中药膏剂，按重量份计，由以下组分配比组成：
Figure PCTCN2016083896-appb-000001
在上述中药膏剂配方中，沙棘果核、黄柏、生地、春黄菊花、连翘、钩藤、南瓜子、川穹和VB5合用可产生强而持久的清热消炎消肿效能。沙棘果核中的沙棘油能抗炎生肌，有效促进组织再生；黄柏对多种致病细菌具有很强的抑制作用，且具有收敛和消炎的作用；生地可用于流畅血脉之瘀滞，活血化瘀；春黄菊花具有优异的抗炎消炎，止痛消肿，促进伤口愈合，同时具有促进细胞再生和皮肤新陈代谢等作用；连翘主治清热解毒、消肿散结；钩藤可用于舒筋活络、消肿镇痛；南瓜子具有消炎止痛作用；川芎可用于活血行气，祛风止痛；VB5的适当添加可用于舒缓皮肤，促进皮肤健康的恢复。
优选的是，其中，按重量份计，由以下组分配比组成：
Figure PCTCN2016083896-appb-000002
Figure PCTCN2016083896-appb-000003
优选的是，其中，所述透皮促进剂包括30～40wt％的薄荷醇、30～40wt％的冰片、15～20wt％的PEG及10～15wt％的辛醇。薄荷醇的添加可改变角质层的通透性，减低药物经皮肤渗透的阻力，提高药物在皮肤角质层的扩散体系，冰片可与薄荷醇产生协同增效作用，有效增加皮肤对药物的吸收；PEG和辛醇可对中药和薄荷醇及冰片起到融合和混合的作用，既增加药物的溶解度，又可显著提高促渗效果的长久性。
优选的是，其中，所述PEG的分子量为400～600，在此分子量下，PEG与药物及其他辅料有良好的相容性，且对药物的透皮效率有最优的促进效果。
优选的是，其中，所述沙棘果核、黄柏、生地、钩藤、川芎分别经粉碎后，混合，然后以85％的乙醇为溶剂，80℃回流提取3次，以促进中药有效成分的溶出。
优选的是，其中，所述春黄菊花、连翘、南瓜子分别经粉碎后，混合，然后以70％的乙醇为溶剂，55～60℃回流提取2次，春黄菊花、连翘和南瓜子的乙醇回流提取温度不能过高，否则会增加无效成分的溶出，降低药效。
优选的是，其中，所述沙棘果核、黄柏、生地、钩藤、川芎分别粉碎至20～25μm，既保证中药有效成分的浸出，又防止中药粒径过细影响过滤。
优选的是，其中，所述85％的乙醇为沙棘果核、黄柏、生地、钩藤和川芎混合体积的5～8倍，每次提取的时间为1～2h，合适的料液比和提取时间保证传质推动力，提高有效物质的提取率。
优选的是，其中，所述春黄菊花、连翘、南瓜子分别粉碎至28～32μm，即可使中药的有效成分充分溶出，以保证有效成分溶出率与粉碎能耗之间的平衡。
优选的是，其中，每次提取，所述70％的乙醇为所述春黄菊花、连翘和南瓜子的4～5倍，每次提取的时间为0.3～0.7h，以保证中药有效成分的溶 出率及批次间的溶出稳定性。
本发明至少包括以下有益效果：
(1)本发明中药膏剂配方中，沙棘果核、黄柏、生地、春黄菊花、连翘、钩藤、南瓜子和川穹的合用可产生强而持久的清热消炎消肿效能，且作用温和，对皮肤无刺激性；
(2)本发明中由合适比例薄荷醇、冰片、PEG及辛醇组成的透皮促进剂的使用，有效改变了皮肤角质层的通透性，减低药物经皮肤渗透的阻力，提高了药物在皮肤角质层的扩散体系，且促渗作用持久；
(3)本发明替代传统的麻油提取方法，根据中草药的不同性质采用不同的醇回流工艺进行提取，既保证了有效成分的充分提取，又避免的提取温度过高而造成的中药膏剂杂质多，药效差。
本发明的其它优点、目标和特征将部分通过下面的说明体现，部分还将通过对本发明的研究和实践而为本领域的技术人员所理解。
具体实施方式
下面结合具体实施例对本发明做进一步的详细说明，以令本领域技术人员参照说明书文字能够据以实施。
应当理解，本文所使用的诸如“具有”、“包含”以及“包括”术语并不配出一个或多个其它元件或其组合的存在或添加。
<实例1>
一种外敷消炎消肿中药膏剂，其按重量份计，由以下组分配比组成：沙棘果核15份；黄柏10份；生地8份；春黄菊花8份；连翘5份；钩藤5份；南瓜子5份；川芎3份；VB5 3份；透皮促进剂3份。
其中，所述透皮促进剂包括30wt％的薄荷醇、40wt％的冰片、20wt％的PEG400及10wt％的辛醇。
其中，所述沙棘果核、黄柏、生地、钩藤、川芎分别经粉碎至平均粒径为20μm后，混合，然后依次以5倍中药混合物的85％的乙醇为溶剂，80℃回流共提取3次，每次均提取1h；所述春黄菊花、连翘、南瓜子分别经粉碎至28μm后，混合，然后依次以4倍春黄菊花、连翘和南瓜子混合物体积的 70％的乙醇为溶剂，55℃回流提取2次，每次提取的时间均为0.3h。
将本实例制备的中药膏剂应用于临床治疗：
张某，男，35岁，因住所环境潮湿，背部生有大片小疙瘩，瘙痒发红，外敷本实例制备的中药膏剂，瘙痒症状得到有效缓解，3天后疙瘩消失，无疤痕，疗效满意。
<实例2>
一种外敷消炎消肿中药膏剂，其按重量份计，由以下组分配比组成：沙棘果核20份；黄柏15份；生地12份；春黄菊花12份；连翘15份；钩藤15份；南瓜子10份；川芎7份；VB5 5份；透皮促进剂5份。
其中，所述透皮促进剂包括40wt％的薄荷醇、35wt％的冰片、15wt％的PEG600及10wt％的辛醇。
其中，所述沙棘果核、黄柏、生地、钩藤、川芎分别经粉碎至平均粒径为25μm后，混合，然后依次以8倍中药混合物的85％的乙醇为溶剂，80℃回流共提取3次，每次提取的时间均为2h。；所述春黄菊花、连翘、南瓜子分别经粉碎至32μm后，混合，然后依次以5倍春黄菊花、连翘和南瓜子混合物体积的70％的乙醇为溶剂，60℃回流共提取2次，每次提取的时间为0.7h。
将本实例制备的中药膏剂应用于临床治疗：
刘某，女，67岁，因脑梗塞致偏瘫半年，久卧在床，骶尾部皮肤形成压之不褪色的红斑，外敷本实例制备的中药膏剂，同时均采取翻身、减压等措施，皮肤有清凉感，且无刺激性，并且红斑逐渐消失，7天后得到治愈。
<实例3>
一种外敷消炎消肿中药膏剂，其按重量份计，由以下组分配比组成：沙棘果核16份；黄柏12份；生地11份；春黄菊花12份；连翘7份；钩藤7份；南瓜子9份；川芎3份；VB5 5份；透皮促进剂4份。
其中，所述透皮促进剂包括35wt％的薄荷醇、35wt％的冰片、15wt％的PEG500及15wt％的辛醇。
其中，所述沙棘果核、黄柏、生地、钩藤、川芎分别经粉碎至平均粒径为23μm后，混合，然后依次以7倍中药混合物的85％的乙醇为溶剂，80℃回流共提取3次，提取的时间分别为2h、1.5h和1h；所述春黄菊花、连翘、 南瓜子分别经粉碎至30μm后，混合，然后依次以4.5倍春黄菊花、连翘和南瓜子混合物体积的70％的乙醇为溶剂，58℃回流共提取2次，提取时间分别为0.5h和0.7h。
将本实例制备的中药膏剂应用于临床治疗：
陈某，男，8岁，因水土不服身上生有片状红肿现象，并有瘙痒感，外敷本实例制备的中药膏剂，瘙痒症状得到有效缓解，3天后红肿现象消失，疗效满意。
<实例4>
一种外敷消炎消肿中药膏剂，其按重量份计，由以下组分配比组成：沙棘果核18份；黄柏14份；生地10份；春黄菊花9份；连翘12份；钩藤12份；南瓜子7份；川芎5份；VB5 4份；透皮促进剂4份。
其中，所述透皮促进剂包括32wt％的薄荷醇、38wt％的冰片、18wt％的PEG400及12wt％的辛醇。
其中，所述沙棘果核、黄柏、生地、钩藤、川芎分别经粉碎至平均粒径为22μm后，混合，然后依次以6倍中药混合物的85％的乙醇为溶剂，80℃回流共提取3次，提取的时间分别为1.5h、1.5h和1h；所述春黄菊花、连翘、南瓜子分别经粉碎至29μm后，混合，然后依次以4倍春黄菊花、连翘和南瓜子混合物体积的70％的乙醇为溶剂，58℃回流共提取2次，提取时间分别为0.7h和0.4h。
将本实例制备的中药膏剂应用于临床治疗：
李某，男，24岁，因运动过激软组织挫伤，腿部出现红肿疼痛现象，外敷本实例制备的中药膏剂，5天后红肿现象完全消失，疗效满意。
<实例5>
一种外敷消炎消肿中药膏剂，其按重量份计，由以下组分配比组成：沙棘果核17份；黄柏13份；生地9份；春黄菊花11份；连翘10份；钩藤10份；南瓜子8份；川芎6份；VB5 5份；透皮促进剂4份。
其中，所述透皮促进剂包括36wt％的薄荷醇、33wt％的冰片、17wt％的PEG500及14wt％的辛醇。
其中，所述沙棘果核、黄柏、生地、钩藤、川芎分别经粉碎至平均粒径 为24μm后，混合，然后以7倍中药混合物的85％的乙醇为溶剂，80℃回流提取3次，提取的时间分别为1.5h、1h和2h；所述春黄菊花、连翘、南瓜子分别经粉碎至31μm后，混合，然后依次5倍春黄菊花、连翘和南瓜子混合物体积的70％的乙醇为溶剂，59℃回流共提取2次，提取时间分别为0.6h和0.5h。
将本实例制备的中药膏剂应用于临床治疗：
谢某，女，42岁，胳膊被蜜蜂蜇伤，蜂刺被拔出后，出现红肿疼痛现象，外敷本实例制备的中药膏剂，疼痛症状得到有效缓解，4天后红肿消失，无疤痕，疗效满意。
可见，由本发明制备得到的外敷消炎消肿中药膏剂作用迅速，可产生强而持久的清热消炎消肿效能，且作用温和，对皮肤无刺激性。
尽管本发明的实施方案已公开如上，但其并不仅仅限于说明书和实施方式中所列运用。它完全可以被适用于各种适合本发明的领域。对于熟悉本领域的人员而言，可容易地实现另外的修改。因此在不背离权利要求及等同范围所限定的一般概念下，本发明并不限于特定的细节和这里示出与描述的实施例。

Claims (10)

  1. 一种外敷消炎消肿中药膏剂，其特征在于，按重量份计，由以下组分配比组成：
    Figure PCTCN2016083896-appb-100001
  2. 如权利要求1所述的外敷消炎消肿中药膏剂，其特征在于，按重量份计，由以下组分配比组成：
    Figure PCTCN2016083896-appb-100002
  3. 如权利要求1所述的外敷消炎消肿中药膏剂，其特征在于，所述透皮促进剂包括30～40wt％的薄荷醇、30～40wt％的冰片、15～20wt％的PEG及10～15wt％的辛醇。
  4. 如权利要求3所述的外敷消炎消肿中药膏剂，其特征在于，所述PEG的分子量为400～600。
  5. 如权利要求1所述的外敷消炎消肿中药膏剂，其特征在于，所述沙棘果核、黄柏、生地、钩藤、川芎分别经粉碎后，混合，然后以85％的乙醇为溶剂，80℃回流提取3次。
  6. 如权利要求1所述的外敷消炎消肿中药膏剂，其特征在于，所述春黄菊花、连翘、南瓜子分别经粉碎后，混合，然后以70％的乙醇为溶剂，55～60℃回流提取2次。
  7. 如权利要求5所述的外敷消炎消肿中药膏剂，其特征在于，所述沙棘果核、黄柏、生地、钩藤、川芎分别粉碎至20～25μm。
  8. 如权利要求5所述的外敷消炎消肿中药膏剂，其特征在于，每次提取，所述85％的乙醇为沙棘果核、黄柏、生地、钩藤和川芎混合体积的5～8倍，每次提取的时间为1～2h。
  9. 如权利要求6所述的外敷消炎消肿中药膏剂，其特征在于，所述春黄菊花、连翘、南瓜子分别粉碎至28～32μm。
  10. 如权利要求6所述的外敷消炎消肿中药膏剂，其特征在于，每次提取，所述70％的乙醇为所述春黄菊花、连翘和南瓜子混合体积的4～5倍，每次提取的时间为0.3～0.7h。
PCT/CN2016/083896 2016-05-30 2016-05-30 外敷消炎消肿中药膏剂 WO2017206016A1 (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201680000512.5A CN108495645B (zh) 2016-05-30 2016-05-30 外敷消炎消肿中药膏剂
PCT/CN2016/083896 WO2017206016A1 (zh) 2016-05-30 2016-05-30 外敷消炎消肿中药膏剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/083896 WO2017206016A1 (zh) 2016-05-30 2016-05-30 外敷消炎消肿中药膏剂

Publications (1)

Publication Number Publication Date
WO2017206016A1 true WO2017206016A1 (zh) 2017-12-07

Family

ID=60479451

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/083896 WO2017206016A1 (zh) 2016-05-30 2016-05-30 外敷消炎消肿中药膏剂

Country Status (2)

Country Link
CN (1) CN108495645B (zh)
WO (1) WO2017206016A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3735258A4 (en) * 2018-01-02 2021-10-13 Skinkick, Llc TOPICAL SKIN CARE COMPOSITIONS
CN113893315A (zh) * 2021-11-25 2022-01-07 顾帆 一种蚊虫叮咬消炎消肿止痒膏及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090504A (zh) * 1993-10-13 1994-08-10 李昆文 外用药消痼净
CN1698745A (zh) * 2005-05-24 2005-11-23 朱瑜琪 一种外用消炎制剂的中药组合物
CN104056018A (zh) * 2014-06-25 2014-09-24 姬光勤 通络消炎止痛膏
CN104225410A (zh) * 2014-08-20 2014-12-24 王冀 一种治疗日光性皮炎的药膏
CN105211367A (zh) * 2015-09-29 2016-01-06 安徽省天旭茶业有限公司 一种消炎抗菌活血枇杷花琥珀茶及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090504A (zh) * 1993-10-13 1994-08-10 李昆文 外用药消痼净
CN1698745A (zh) * 2005-05-24 2005-11-23 朱瑜琪 一种外用消炎制剂的中药组合物
CN104056018A (zh) * 2014-06-25 2014-09-24 姬光勤 通络消炎止痛膏
CN104225410A (zh) * 2014-08-20 2014-12-24 王冀 一种治疗日光性皮炎的药膏
CN105211367A (zh) * 2015-09-29 2016-01-06 安徽省天旭茶业有限公司 一种消炎抗菌活血枇杷花琥珀茶及其制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAI, ZAIXIAN ET AL.: "The Medicine and Health Effect of Shaji", LISHIZHEN MEDICINE AND MATERIA MEDICA RESEARCH, vol. 10, no. 02, 10 February 1999 (1999-02-10), pages 147 - 148 *
LIU, YUNXI ET AL.: "Two Kinds of European Conventional Chamomiles", WORLD PHYTOMEDICINES, vol. 11, no. 03, 31 December 1996 (1996-12-31), pages 116 - 118 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3735258A4 (en) * 2018-01-02 2021-10-13 Skinkick, Llc TOPICAL SKIN CARE COMPOSITIONS
CN113893315A (zh) * 2021-11-25 2022-01-07 顾帆 一种蚊虫叮咬消炎消肿止痒膏及其制备方法

Also Published As

Publication number Publication date
CN108495645A (zh) 2018-09-04
CN108495645B (zh) 2021-04-20

Similar Documents

Publication Publication Date Title
CN101933991B (zh) 一种镇痛抗炎药物及其制备方法
CN100444889C (zh) 一种用于治疗乳腺增生病的中药组合物
KR20100079858A (ko) 천연광물과 한약재를 주원료로 한 피부질환 치료용 외용제
CN104825914A (zh) 一种辅助治疗乳腺癌症的中药制剂
CN101829278B (zh) 一种速效消炎止痛的中草药制剂
WO2017206016A1 (zh) 外敷消炎消肿中药膏剂
CN108002997B (zh) 一种具有止呕作用的沉香提取物及其应用
DE202004018534U1 (de) Kräuterzusammensetzung zur Vermeidung und/oder Behandlung von Zuständen in Verbindung mit Depression
CN105287742A (zh) 一种防治蚊虫叮咬的药膏及其制备方法
CN103520289B (zh) 一种治疗便秘的中药组合物及其制备方法和应用
CN105362385A (zh) 一种中药益母草免煎剂的制备方法
CN100400093C (zh) 一种减轻患者疼痛的外用药
CN111840494B (zh) 抗痛风中药组合物、其制备方法及其应用
CN103977112A (zh) 一种治疗酒精肝的中药
CN103585298A (zh) 一种治疗蚊叮虫咬的中药外用药液
CN103239646B (zh) 一种用于治疗白癜风的中药有效部位组合物及其制备方法
Javed Sharbat-E-Unnab: A Review on Potent Unani Formulation
CN105560837A (zh) 治疗皮肤损伤的药物及其制备方法
CN106692698B (zh) 一种白芨止咳颗粒及其制备方法
CN105030983A (zh) 一种治疗湿疹的外用中药
CN105232664A (zh) 一种外敷坐骨神经的膏贴
CN104940761A (zh) 用于治疗气喘咳嗽的膏药
CN101822767B (zh) 用于治疗骨质和骨神经类疾病的外用药贴
CN116270915A (zh) 一种青蒿膏及其制备方法和应用
CN110974913A (zh) 一种消炎止痛外用药膏、其应用及服用方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16903404

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16903404

Country of ref document: EP

Kind code of ref document: A1